Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
20,749,933
-
Share change
-
-6,075,809
-
Total reported value
-
$218,131,044
-
Put/Call ratio
-
157%
-
Price per share
-
$10.51
-
Number of holders
-
112
-
Value change
-
-$52,180,727
-
Number of buys
-
49
-
Number of sells
-
69
Institutional Holders of INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) as of Q1 2017
As of 31 Mar 2017,
INSYS THERAPEUTICS INC NEW - COM NEW (INSYQ) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,749,933 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BlackRock Inc., VANGUARD GROUP INC, Folger Hill Asset Management LP, NORGES BANK, DIMENSIONAL FUND ADVISORS LP, Invesco Ltd., STATE STREET CORP, Fine Capital Partners, L.P., and Point72 Asset Management, L.P..
This page lists
112
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.